Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
421.39
-1.24 (-0.29%)
At close: Oct 24, 2025, 4:00 PM EDT
421.00
-0.39 (-0.09%)
After-hours: Oct 24, 2025, 7:16 PM EDT

Vertex Pharmaceuticals Statistics

Total Valuation

VRTX has a market cap or net worth of $108.04 billion. The enterprise value is $97.54 billion.

Market Cap108.04B
Enterprise Value 97.54B

Important Dates

The next confirmed earnings date is Monday, November 3, 2025, after market close.

Earnings Date Nov 3, 2025
Ex-Dividend Date n/a

Share Statistics

VRTX has 256.39 million shares outstanding. The number of shares has increased by 0.19% in one year.

Current Share Class 256.39M
Shares Outstanding 256.39M
Shares Change (YoY) +0.19%
Shares Change (QoQ) -0.23%
Owned by Insiders (%) 0.20%
Owned by Institutions (%) 96.18%
Float 255.58M

Valuation Ratios

The trailing PE ratio is 29.95 and the forward PE ratio is 21.87. VRTX's PEG ratio is 0.15.

PE Ratio 29.95
Forward PE 21.87
PS Ratio 9.49
Forward PS 8.37
PB Ratio 6.29
P/TBV Ratio 6.90
P/FCF Ratio 30.87
P/OCF Ratio 28.09
PEG Ratio 0.15
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.19, with an EV/FCF ratio of 27.87.

EV / Earnings 26.81
EV / Sales 8.54
EV / EBITDA 21.19
EV / EBIT 22.02
EV / FCF 27.87

Financial Position

The company has a current ratio of 2.52, with a Debt / Equity ratio of 0.09.

Current Ratio 2.52
Quick Ratio 2.00
Debt / Equity 0.09
Debt / EBITDA 0.32
Debt / FCF 0.44
Interest Coverage 260.54

Financial Efficiency

Return on equity (ROE) is 22.77% and return on invested capital (ROIC) is 16.09%.

Return on Equity (ROE) 22.77%
Return on Assets (ROA) 12.53%
Return on Invested Capital (ROIC) 16.09%
Return on Capital Employed (ROCE) 22.26%
Revenue Per Employee $1.87M
Profits Per Employee $596,328
Employee Count6,100
Asset Turnover 0.52
Inventory Turnover 4.49

Taxes

In the past 12 months, VRTX has paid $736.40 million in taxes.

Income Tax 736.40M
Effective Tax Rate 16.84%

Stock Price Statistics

The stock price has decreased by -10.35% in the last 52 weeks. The beta is 0.43, so VRTX's price volatility has been lower than the market average.

Beta (5Y) 0.43
52-Week Price Change -10.35%
50-Day Moving Average 398.99
200-Day Moving Average 445.48
Relative Strength Index (RSI) 60.49
Average Volume (20 Days) 1,411,561

Short Selling Information

The latest short interest is 3.56 million, so 1.39% of the outstanding shares have been sold short.

Short Interest 3.56M
Short Previous Month 4.05M
Short % of Shares Out 1.39%
Short % of Float 1.39%
Short Ratio (days to cover) 2.11

Income Statement

In the last 12 months, VRTX had revenue of $11.42 billion and earned $3.64 billion in profits. Earnings per share was $14.07.

Revenue11.42B
Gross Profit 6.00B
Operating Income 4.43B
Pretax Income 4.37B
Net Income 3.64B
EBITDA 4.60B
EBIT 4.43B
Earnings Per Share (EPS) $14.07
Full Income Statement

Balance Sheet

The company has $6.38 billion in cash and $1.53 billion in debt, giving a net cash position of $10.50 billion or $40.96 per share.

Cash & Cash Equivalents 6.38B
Total Debt 1.53B
Net Cash 10.50B
Net Cash Per Share $40.96
Equity (Book Value) 17.18B
Book Value Per Share 67.01
Working Capital 6.29B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $3.85 billion and capital expenditures -$346.70 million, giving a free cash flow of $3.50 billion.

Operating Cash Flow 3.85B
Capital Expenditures -346.70M
Free Cash Flow 3.50B
FCF Per Share $13.65
Full Cash Flow Statement

Margins

Gross margin is 52.54%, with operating and profit margins of 38.79% and 31.86%.

Gross Margin 52.54%
Operating Margin 38.79%
Pretax Margin 38.31%
Profit Margin 31.86%
EBITDA Margin 40.32%
EBIT Margin 38.79%
FCF Margin 30.65%

Dividends & Yields

VRTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.19%
Shareholder Yield -0.19%
Earnings Yield 3.37%
FCF Yield 3.24%
Dividend Details

Analyst Forecast

The average price target for VRTX is $491.78, which is 16.70% higher than the current price. The consensus rating is "Buy".

Price Target $491.78
Price Target Difference 16.70%
Analyst Consensus Buy
Analyst Count 26
Revenue Growth Forecast (5Y) 9.75%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 24, 2000. It was a forward split with a ratio of 2:1.

Last Split Date Aug 24, 2000
Split Type Forward
Split Ratio 2:1

Scores

VRTX has an Altman Z-Score of 12.59 and a Piotroski F-Score of 5.

Altman Z-Score 12.59
Piotroski F-Score 5